# Betaferon® Regulatory Post-Marketing Surveillance

> **NCT01414816** · — · COMPLETED · sponsor: **Bayer** · enrollment: 355 (actual)

## Conditions studied

- Multiple Sclerosis
- Clinically Isolated System

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT01414816
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414816, "Betaferon® Regulatory Post-Marketing Surveillance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01414816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*